CITI risk factor coefficients
| Risk factor . | HR . | Weighted coefficient . |
|---|---|---|
| MTNKN histology | ||
| PTCL, NOS | 2.64 | 0.97 |
| ALCL, ALK+ | 0.56 | −0.58 |
| EATL (includes EATL and MEITL) | 2.92 | 1.07 |
| SPTCL (includes SPTCL and PCGD-TCL) | 0.86 | −0.15 |
| Elevated LDH | 1.10 | 0.10 |
| Stage ≥III | 1.04 | 0.04 |
| B symptoms | 1.15 | 0.14 |
| ≥2 sites of EN involvement (including BM/PB) | 2.66 | 0.98 |
| Risk factor . | HR . | Weighted coefficient . |
|---|---|---|
| MTNKN histology | ||
| PTCL, NOS | 2.64 | 0.97 |
| ALCL, ALK+ | 0.56 | −0.58 |
| EATL (includes EATL and MEITL) | 2.92 | 1.07 |
| SPTCL (includes SPTCL and PCGD-TCL) | 0.86 | −0.15 |
| Elevated LDH | 1.10 | 0.10 |
| Stage ≥III | 1.04 | 0.04 |
| B symptoms | 1.15 | 0.14 |
| ≥2 sites of EN involvement (including BM/PB) | 2.66 | 0.98 |
Abbreviations are explained in Table 1.